🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hidradenitis suppurativa (HS) is a painful, long-term skin condition that c...
Status
Completed
Location
Hs0001 121
Start Date
2017-09-22
Trial ID
NCT03248531
Treatments Being Tested
To evaluate the safety of UCB4940 administered by iv infusion of a single a...
Status
Completed
Location
1
Start Date
2012-11
Trial ID
NCT02529956
The purpose of the study is to compare the pharmacokinetics (PK) of bimekiz...
Status
Terminated
Location
Up0068 001
Start Date
2020-02-12
Trial ID
NCT04255862
Treatments Being Tested
This is a study to assess the long-term safety, long-term efficacy and tole...
Status
Completed
Location
Pa0012 50017
Start Date
2019-08-13
Trial ID
NCT04009499
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of bimekizu...
Status
Completed
Location
As0013 908
Start Date
2017-10-04
Trial ID
NCT03215277
Treatments Being Tested
This is a study to compare the efficacy of bimekizumab versus adalimumab in...
Status
Completed
Location
Ps0008 957
Start Date
2018-01-26
Trial ID
NCT03412747
Treatments Being Tested
The purpose of the study is to evaluate the safety of long-term therapy of ...
Status
Completed
Location
Hs0005 50140
Start Date
2021-05-27
Trial ID
NCT04901195
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy of bimekizuma...
Status
Active Not Recruiting
Location
Ps0021 50162
Start Date
2024-06-25
Trial ID
NCT06425549
Treatments Being Tested
The purpose of the study is to evaluate the pharmakokinetics (PK), safety, ...
Status
Completed
Location
Up0033 002
Start Date
2018-10-15
Trial ID
NCT03707717
Treatments Being Tested
This is a study to evaluate the dose response based on the efficacy, safety...
Status
Completed
Location
Pa0008 007
Start Date
2016-10
Trial ID
NCT02969525
Treatments Being Tested